Stella S. Yu

2.4k total citations
17 papers, 335 citations indexed

About

Stella S. Yu is a scholar working on Physiology, Immunology and Organic Chemistry. According to data from OpenAlex, Stella S. Yu has authored 17 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Immunology and 5 papers in Organic Chemistry. Recurrent topics in Stella S. Yu's work include Asthma and respiratory diseases (9 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Chemical Synthesis and Analysis (3 papers). Stella S. Yu is often cited by papers focused on Asthma and respiratory diseases (9 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Chemical Synthesis and Analysis (3 papers). Stella S. Yu collaborates with scholars based in United States and France. Stella S. Yu's co-authors include Stevan W. Djurić, Thomas D. Penning, Richard A. Haack, Julie M. Miyashiro, Vincent J. Kalish, James F. Kachur, D. J. Fretland, Peter C. Isakson, Tadimeti S. Rao and Doreen Villani-Price and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Stella S. Yu

17 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stella S. Yu United States	11	175	119	62	60	47	17	335
Julie M. Miyashiro United States	12	355 2.0×	164 1.4×	42 0.7×	119 2.0×	63 1.3×	15	536
Tai Wei Ly Taiwan	13	178 1.0×	139 1.2×	83 1.3×	49 0.8×	32 0.7×	26	435
Frederick Wong United States	11	179 1.0×	212 1.8×	47 0.8×	58 1.0×	53 1.1×	18	456
Gregory R. Luedtke United States	11	253 1.4×	158 1.3×	54 0.9×	48 0.8×	58 1.2×	15	425
Michael K. Tong United States	5	236 1.3×	219 1.8×	30 0.5×	60 1.0×	16 0.3×	5	349
Timothy B. Durham United States	15	248 1.4×	232 1.9×	47 0.8×	88 1.5×	28 0.6×	21	518
Sung‐Kee Chung South Korea	12	171 1.0×	211 1.8×	22 0.4×	38 0.6×	24 0.5×	31	401
Hiroo Koyama Japan	13	235 1.3×	252 2.1×	21 0.3×	51 0.8×	38 0.8×	28	547
Koichiro Morihira Japan	13	353 2.0×	178 1.5×	75 1.2×	135 2.3×	315 6.7×	24	629
Lorna H. Mitchell United States	10	148 0.8×	254 2.1×	56 0.9×	15 0.3×	40 0.9×	26	504

Countries citing papers authored by Stella S. Yu

Since Specialization

Citations

This map shows the geographic impact of Stella S. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella S. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella S. Yu more than expected).

Fields of papers citing papers by Stella S. Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella S. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella S. Yu. The network helps show where Stella S. Yu may publish in the future.

Co-authorship network of co-authors of Stella S. Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Stella S. Yu. A scholar is included among the top collaborators of Stella S. Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella S. Yu. Stella S. Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Penning, Thomas D., Mark A. Russell, Helen Y. Chen, et al.. (2004). Synthesis of cinnamic acids and related isosteres as potent and selective αvβ3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(6). 1471–1476. 14 indexed citations

Penning, Thomas D., Mark A. Russell, Helen Y. Chen, et al.. (2002). Synthesis of Potent Leukotriene A₄ Hydrolase Inhibitors. Identification of 3-[Methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic Acid. Journal of Medicinal Chemistry. 45(16). 3482–3490. 29 indexed citations

Penning, Thomas D., Leslie J. Askonas, Stevan W. Djurić, et al.. (1996). ChemInform Abstract: Kelatorphan and Related Analogues: Potent and Selective Inhibitors of Leukotriene A4 Hydrolase.. ChemInform. 27(9). 3 indexed citations

Fretland, D. J., Meire Bremer, Peter C. Isakson, et al.. (1995). Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: Impact upon Leukotriene B4- and 12(R)-HETE- mediated events. Inflammation. 19(2). 193–205. 15 indexed citations

Penning, Thomas D., Stevan W. Djurić, Julie M. Miyashiro, et al.. (1995). Second Generation Leukotriene B4 Receptor Antagonists Related to SC-41930: Heterocyclic Replacement of the Methyl Ketone Pharmacophore. Journal of Medicinal Chemistry. 38(6). 858–868. 18 indexed citations

Penning, Thomas D., Leslie J. Askonas, Stevan W. Djurić, et al.. (1995). Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase. Bioorganic & Medicinal Chemistry Letters. 5(21). 2517–2522. 23 indexed citations

Tsai, B S, Robert H. Keith, Doreen Villani-Price, et al.. (1994). The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1499–1505. 12 indexed citations

Rao, Tadimeti S., Stella S. Yu, Stevan W. Djurić, & Peter C. Isakson. (1994). Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.. PubMed. 10(3). 213–28. 18 indexed citations

Djurić, Stevan W., Stella S. Yu, Timothy S. Gaginella, et al.. (1994). Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity. Bioorganic & Medicinal Chemistry Letters. 4(6). 811–816. 17 indexed citations

10.

Penning, Thomas D., Stevan W. Djurić, Stella S. Yu, et al.. (1993). The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930. Inflammation Research. 39(S1). C11–C13. 3 indexed citations

11.

Fretland, D. J., et al.. (1993). Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Inflammation. 17(3). 353–360. 9 indexed citations

12.

Fretland, D. J., et al.. (1992). Optical isomers of a leukotriene b₄ antagonist have differential effects on granulocyte diapedesis in the guinea pig dermis. Chirality. 4(6). 353–355. 5 indexed citations

13.

Pitzele, Barnett S., Gary W. Gullikson, David M. Albin, et al.. (1990). Potential antisecretory antidiarrheals. 2. .alpha.2-Adrenergic 2-[(aryloxy)alkyl]imidazolines. Journal of Medicinal Chemistry. 33(2). 614–626. 18 indexed citations

14.

Penning, Thomas D., Stevan W. Djurić, Richard A. Haack, et al.. (1990). Improved Procedure for the Reduction of N-Acyloxazolidinones. Synthetic Communications. 20(2). 307–312. 129 indexed citations

15.

Djurić, Stevan W., Richard A. Haack, & Stella S. Yu. (1989). Synthesis of (±)-benzoleukotriene B₃: a novel leukotriene B₄analogue. Journal of the Chemical Society Perkin Transactions 1. 2133–2134. 1 indexed citations

16.

Haack, Richard A., et al.. (1988). Substituted 2-[(2-benzimidazolylsulfinyl)methyl]anilines as potential inhibitors of H+/K+ ATPase. Journal of Medicinal Chemistry. 31(6). 1215–1220. 14 indexed citations

17.

Yu, Stella S., et al.. (1987). A Facile Synthesis of 2-Aminonicotinaldehyde. Synthetic Communications. 17(14). 1695–1699. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact